These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dromotropic effects of oral theophylline in patients with atrial fibrillation and a slow ventricular response. Alboni P; Ratto B; Scarfo S; Rossi P; Cappato R; Paparella N Eur Heart J; 1991 May; 12(5):630-4. PubMed ID: 1874263 [TBL] [Abstract][Full Text] [Related]
10. Management of atrial fibrillation in the elderly. Aronow WS Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738 [TBL] [Abstract][Full Text] [Related]
11. Impact of pulmonary vein isolation on the autonomic modulation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses. Miyanaga S; Yamane T; Date T; Tokuda M; Aramaki Y; Inada K; Shibayama K; Matsuo S; Miyazaki H; Abe K; Sugimoto K; Mochizuki S; Yoshimura M Europace; 2009 May; 11(5):576-81. PubMed ID: 19363052 [TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
13. Hydralazine in the management of symptomatic sinus bradycardia. Weiss AT; Rod JL; Gotsman MS; Lewis BS Eur J Cardiol; 1981; 12(5):261-70. PubMed ID: 7250168 [TBL] [Abstract][Full Text] [Related]
14. Sequential use of aminophylline and theophylline for the treatment of atropine-resistant bradycardia after spinal cord injury: a case report. Sakamoto T; Sadanaga T; Okazaki T J Cardiol; 2007 Feb; 49(2):91-6. PubMed ID: 17354583 [TBL] [Abstract][Full Text] [Related]
15. Theophylline--an alternative therapy for bradyarrhythmia in the elderly. Kragie L; Sekovski B Pharmacotherapy; 1992; 12(4):324-30. PubMed ID: 1518730 [TBL] [Abstract][Full Text] [Related]
16. Theophylline for chronic symptomatic bradycardia in the elderly. Ling CA; Crouch MA Ann Pharmacother; 1998; 32(7-8):837-9. PubMed ID: 9681101 [TBL] [Abstract][Full Text] [Related]
17. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients. Doesch AO; Ammon K; Konstandin M; Celik S; Kristen A; Frankenstein L; Buss S; Hardt S; Sack FU; Katus HA; Dengler TJ Transplantation; 2009 Sep; 88(6):835-41. PubMed ID: 19920784 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of heart rate as an independent predictor for survival after heart transplantation. Anand RG; Reddy MT; Yau CL; Myers L; Amin RR; Stahls PF; Dumas D; Frohlich ED; Ventura HO Am J Cardiol; 2009 May; 103(9):1290-4. PubMed ID: 19406274 [TBL] [Abstract][Full Text] [Related]